Skip to content
TAPS+ Home Page_Landscape
SAGCSep 23, 2026, 10:36:24 AM2 min read

TAPS+ Whole-Genome Methylation Sequencing Now Available at SAGC

One Assay. Genome + Methylome. At a Lower Cost. 

A cost-effective 5-base approach to whole-genome methylation

The South Australian Genomics Centre (SAGC) has expanded its epigenomics capabilities with the introduction of Watchmaker Genomics TAPS+ whole-genome methylation sequencing, providing researchers with a new approach to studying DNA methylation and genetic variation together at whole-genome scale at approximately 30% lower cost than comparable 5-base whole-genome approaches. 

Making larger methylation studies more accessible

Methyl-Seq TAPS Diagram

DNA methylation adds an important layer of information beyond the four bases of the genome. By measuring A, T, G, C and 5mC, 5-base sequencing can provide an integrated view of genetic variation and DNA methylation across the genome.

The Watchmaker DNA Library Prep Kit with TAPS+ (distributed by TrendBio in Australia) uses a positive-readout approach that converts methylated cytosines while preserving unmethylated cytosines.

By retaining much more of the native four-base sequence complexity, TAPS+ supports efficient genome alignment and enables genomic variant analysis alongside genome-wide methylation detection.

From the same library, researchers can investigate:

  • Genome-wide 5mC DNA methylation
  • Single nucleotide variants (SNVs)
  • Insertions and deletions
  • Copy-number variation
  • Relationships between genetic variation and epigenetic regulation

This dual-omics approach is particularly valuable for studies seeking to understand how variation in the underlying genome interacts with epigenetic regulation

Whole-genome discovery without predefined targets

DNA methylation is an important layer of epigenetic regulation involved in gene expression, development, ageing and disease. Whole-genome methylation sequencing provides the opportunity to investigate these patterns without restricting analysis to a predetermined panel of CpG sites.

TAPS+ takes a different approach from conventional methylation sequencing. Rather than converting unmethylated cytosines, its positive-readout chemistry selectively converts methylated cytosines (5mC) while preserving unmethylated cytosines. This retains much more of the native four-base sequence complexity and avoids the DNA damage associated with traditional bisulfite conversion.

→ Visit the Watchmaker Genomics website (TrendBio - Australian Distributor)

→ News article: Two Omics, One Library - TAPS+ and DNBSEQ evaluation demonstrated dual-omics capability, with SNP calling performed alongside methylation analysis from the same TAPS+ libraries. 

 

Resources

→ View SAGC & TrendBio TAPS+ Brochure overview of performance data and a summary of key features and benefits.

 

Applications across biomedical research

Whole-genome TAPS+ sequencing can support a broad range of epigenomics research, including:

    • Cancer epigenomics and tumour profiling
    • Ageing and epigenetic clock research
    • Population-scale methylation studies
    • Biomarker discovery
    • FFPE and archival tissue cohorts
    • Developmental biology
    • Neuroscience
    • Integrated genetic and epigenetic studies

For Research Use Only. Not for use in diagnostic procedures.

 
Interested in discussing our Methyl-seq services?

Contact the SAGC to learn more about our services or ask about pricing -SAGC can assist with project planning, experimental design, sequencing, bioinformatics, and downstream data analysis.

COMMENTS

RELATED ARTICLES